Fungitraxx

RSS

itraconazole

Authorised
This medicine is authorised for use in the European Union.

Overview

This is a summary of the European Public Assessment Report. Its purpose is to explain how the assessment done by the Committee for Medicinal Products for Veterinary Use (CVMP) on the basis of the documentation provided, led to the recommendations on the conditions of use.

This summary cannot replace a face-to-face discussion with your veterinarian. If you need more information about your animal’s medical condition or treatment, contact your veterinarian. If you want more information on the basis of the CVMP recommendations, read the scientific discussion (also part of the EPAR).

This EPAR was last updated on 27/03/2019

Authorisation details

Product details
Name
Fungitraxx
Agency product number
EMEA/V/C/002722
Active substance
Itraconazole
International non-proprietary name (INN) or common name
itraconazole
Species
Avian
Anatomical therapeutic chemical veterinary (ATCvet) codes
QJ02AC02
Publication details
Marketing-authorisation holder
Avimedical B.V.
Revision
2
Date of issue of marketing authorisation valid throughout the European Union
12/03/2014
Contact address
Abbinkdink 1
7255 XL Helgel (Gld)
Netherlands

Product information

14/03/2019 Fungitraxx - EMEA/V/C/002722 - R/0004

Contents

Please note that the size of the above document can exceed 50 pages.

You are therefore advised to be selective about which sections or pages you wish to print.

Pharmacotherapeutic group

  • ANTIMYCOTICS FOR SYSTEMIC USE
  • Triazole derivatives
  • itraconazole

Therapeutic indication

For the treatment of aspergillosis and candidiasis in companion birds

Assessment history

How useful was this page?

Add your rating